EPIRUS Biopharmaceuticals, Inc. (EPRSQ) has 12 identified peers for comparison in the Healthcare sector. Peers include AMTI, ANTX, CNTA, CYT, ERAS, EWTX and others.
EPRSQ has a market capitalization of $1.57K, compared to an average peer market cap of $1.47B. EPRSQ is notably smaller than its average peer.